Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147
Titel:
Comparison of FOLFIRI With or Without Cetuximab in Patients With Resected Stage III Colon Cancer; NCCTG (Alliance) Intergroup Trial N0147
Auteur:
Huang, Jocelin Nair, Suresh G. Mahoney, Michelle R. Nelson, Garth D. Shields, Anthony F. Chan, Emily Goldberg, Richard M. Gill, Sharlene Kahlenberg, Morton S. Quesenberry, James T. Thibodeau, Stephen N. Smyrk, Thomas C. Grothey, Axel Sinicrope, Frank A. Webb, Thomas A. Farr Jr., Gist H. Pockaj, Barbara A. Berenberg, Jeffrey L. Mooney, Margaret Sargent, Daniel J. Alberts, Steven R.